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Abstract
Background: The human egg coat, zona pellucida (ZP), is composed of four glycoproteins designated as zona
pellucida glycoprotein-1 (ZP1), -2 (ZP2), -3 (ZP3) and -4 (ZP4) respectively. The zona proteins possess the archetypal
‘ZP domain’, a signature domain comprised of approximately 260 amino acid (aa) residues. In the present
manuscript, attempts have been made to delineate the functional significance of the ‘ZP domain’ module of
human ZP1, corresponding to 273-551 aa fragment of human ZP1.
Methods: Baculovirus-expressed, nickel-nitrilotriacetic acid affinity chromatography purified ‘ZP domain’ of human
ZP1 was employed to assess its capability to bind and subsequently induce acrosomal exocytosis in capacitated
human spermatozoa using tetramethyl rhodamine isothiocyanate conjugated Pisum sativum Agglutinin in absence
or presence of various pharmacological inhibitors. Binding characteristics of ZP1 ‘ZP domain’ were assessed
employing fluorescein isothiocyanate (FITC) labelled recombinant protein.
Results: SDS-PAGE and immunoblot characterization of the purified recombinant protein (both from cell lysate as
well as culture supernatant) revealed a doublet ranging from ~35-40 kDa. FITC- labelled ‘ZP domain’ of ZP1 binds
primarily to the acrosomal cap of the capacitated human spermatozoa. A dose dependent increase in acrosomal
exocytosis was observed when capacitated sperm were incubated with recombinant ‘ZP domain’ of human ZP1.
The acrosome reaction mediated by recombinant protein was independent of Gi protein-coupled receptor
pathway, required extra cellular calcium and involved both T- and L-type voltage operated calcium channels.
Conclusions: Results described in the present study suggest that the ‘ZP domain’ module of human ZP1 has
functional activity and may have a role during fertilization in humans.
Background
Mammalian oocyte is surrounded by a glycoproteinac-
eous extracellular coat termed as zona pellucida (ZP).
During fertilization, the ZP matrix plays a crucial role by
serving as a substrate for sperm binding, as well as an
agonist for regulated exocytosis of the spermatozoon’s
acrosomal vesicle and facilitates avoidance of polyspermy
[1]. It also acts as a protective barrier around the embryo
during early stages of its development till the implanta-
tion of the blastocyst in the endometrium takes place.
Human ZP matrix is composed of 4 glycoproteins desig-
nated as zona pellucida glycoprotein-1 [ZP1; 638 amino
acid (aa)], -2 (ZP2; 745 aa), -3 (ZP3; 424 aa) and -4 (ZP4;
540 aa) [2-4]. The role of respective ZP glycoproteins
during different stages of fertilization has been a subject
of intense scrutiny. Studies employing recombinant
human ZP3, expressed in various expression systems,
suggest that as in mouse, in humans, ZP3 also binds to
the capacitated spermatozoa and induces acrosomal
exocytosis [5-12]. The role of human ZP3 as putative
primary sperm receptor has been further confirmed by
employing immunoaffinity purified native ZP3 from
human oocytes [13,14]. In contrast to mouse model, in
humans, ZP4 [pseudogene in mice, 15] also binds to the
anterior head of the capacitated acrosome-intact sperma-
tozoa and induces acrosomal exocytosis [9,11-14]. Recent
studies from our group employing baculovirus-expressed
recombinant human ZP1 have demonstrated its role in
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reaction [16], whereas in murine model, ZP1 has been
postulated to cross-link the filaments formed by ZP2-
ZP3 heterodimers [17] and may not have any direct role
in induction of acrosome reaction [18]. Similar to murine
model, in humans, ZP2 fails to induce acrosomal exo-
cytosis in capacitated human spermatozoa and predomi-
nantly binds to acrosome-reacted spermatozoa thus,
acting as a secondary sperm receptor [1,9,11-14].
The biochemical characterization of ZP glycoproteins
revealed that these share several common structural fea-
tures that include i) N-terminal hydrophobic signal pep-
tide sequence, ii) potential N- and O-linked glycosylation
sites, iii) a C-terminal hydrophobic transmembrane-like
domain (TMD), iv) a potential consensus proprotein con-
vertase (furin) cleavage site (CFCS) upstream of TMD,
and v) ‘ZP domain’ [19-21]. The formation of ZP matrix
involves regulated proteolysis at CFCS by a member of the
furin convertase family [22]. The ‘ZP domain’ consists of
approximately 260 aa including 8 conserved Cys residues
and is predicted to have high b-strand content with addi-
tional conservation of hydrophobicity, polarity and turn
forming tendency at a number of positions [21]. ‘ZP
domain’ has been shown to play an important role in poly-
merization of extracellular matrix proteins including ZP
matrix [20,23]. This domain is also found in other proteins
like the transforming growth factor (TGF)-bR III, uromo-
dulin, pancreatic secretory granule protein GP2, a-a n db-
tectorins, DMBT-1 (deleted in malignant brain tumor-1),
NompA (no-mechanoreceptor-potential-A), Dumpy and
Cuticulin-1, Drosophila genes miniature and dusky,e t c .
[20,21]. ‘ZP domain’ has a bipartite structure with ZP-N
and ZP-C sub-domains separated by a linker region [21].
The ZP-N sub-domain has been shown to be self-suffi-
cient for polymerization [23]. Recently, 2.3Å crystal struc-
ture of the ZP-N sub-domain of murine ZP3 has been
solved which will provide important framework to study
the ‘ZP domain’ family proteins [24]. The role of ZP-C
sub-domain is not as yet clearly defined.
In this manuscript, the functional significance of ‘ZP
domain’ of human ZP1 has been investigated. The
human Zp1 gene encodes a 638 aa long protein, which
has a 25 aa long N-terminal signal peptide, a ‘ZP
domain’ ranging from 279-548 aa and a tetrabasic
CFCS, RQRR (552-555 aa) upstream of TMD. Human
ZP1 ‘ZP domain’ (273-551 aa residues; ZP1273-551aa)h a s
been cloned and expressed using baculovirus expression
system to obtain it in the glycosylated form. Recombi-
nant ZP1273-551aa has been investigated for its binding to
capacitated human spermatozoa, induction of acrosomal
exocytosis and delineation of the downstream signalling
events associated with acrosomal exocytosis using phar-
macological inhibitors.
Methods
Expression of ‘ZP domain’ of human ZP1 using
baculovirus expression system
To clone and express ZP1273-551aa in baculovirus, human
ZP1 fragment corresponding to nucleotide (nt) 757-1653
(897 bp) was used as template which was PCR amplified
from a commercially obtained adaptor-based human
ovarian cDNA library (Marathon Ready cDNA library,
BD Biosciences, Clontech, USA). Primers were designed
based on the sequence published in the GenBank having
the accession number NM_207341. The sequence for a
6× His tag was inserted in the reverse primer to facili-
tate easy purification of the expressed protein employing
Ni-NTA affinity chromatography. The PCR amplifica-
tion was performed in 50 μl reaction volume comprising
of a 10× high fidelity PCR reaction buffer [600 mM Tris
sulfate (pH 8.9), 180 mM ammonium sulfate], using 10-
20 ng of the template DNA, 50 pmole of the forward
(5’-CGGGATCCCGGCAACACAGCTACTGTC-3’)a n d
the reverse (5’-CGGAATTCTTA GTGGTGGTGGT
GGTGGTGTGTAGTGCCAGTGCTACA-3) primers,
50 mM MgSO4, 10 mM dNTPs and 1 unit (U) of Plati-
num Taq DNA polymerase high fidelity (Invitrogen
Corp., Carlsbad, CA, USA) for extension. The template
was initially denatured at 94°C for 10 min followed by
amplification, which was carried out for 25 cycles of
denaturation at 94°C for 60 sec, primer annealing at
52°C for 90 sec and extension at 72°C for 90 sec
followed by a final extension at 72°C for 15 minutes.
Subsequent cloning of the PCR amplified product into
the baculovirus transfer vector pAcGP67-A (PharMin-
gen, San Diego, CA, USA) and generation of the recom-
binant baculovirus expressing the above recombinant
protein was performed as described previously [16]. To
obtain the recombinant protein, 50 × 10
6 Spodoptera
frugiperda (Sf21) insect cells growing in a suspension
culture in Spinner bottles (Thermolyne; Barnstead Inter-
national, Dubuque, IA, USA) were incubated with the
recombinant virus at a multiplicity of infection (MOI) of
3 at 42 rotations per minute (rpm) for 96 h after which
the cells were pelleted at 1000 g for 15 min. The recom-
binant protein was purified under denaturing conditions
using Ni-NTA resin [25] and subsequently renatured by
extensive dialysis against renaturation buffer [50 mM
Tris-HCl pH 8.5, 1 mM EDTA (ethylenediaminetetraa-
cetic acid; Amresco, Solon, Ohio, USA), 0.1 mM
reduced glutathione (Amresco), 0.01 mM oxidized glu-
tathione (Amresco) and 10% sucrose (Sigma-Aldrich
I n c . ,S t .L o u i s ,M O ,U S A ) ]f o r9 6hw i t h6c h a n g e so f
the dialysis buffer with decreasing concentrations of
urea (4 M, 3 M, 2 M, 1 M, 0.5 M and finally buffer
without urea) to assist in removal of urea and refolding
of the protein. The refolded protein was further dialyzed
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551aa, culture supernatant was dialyzed against phosphate
buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8.0)
followed by purification under denaturing conditions
using Ni-NTA affinity column essentially as described
above from the cell pellet.
Characterization of recombinant human ZP1273-551aa
The purified recombinant human ZP1273-551aa was char-
acterized by SDS-PAGE and Western blot as described
previously [11]. In brief, the protein (2-5 μg/lane) was
boiled for 10 min in 2× sample buffer (0.0625 M Tris pH
6.8, 2% SDS, 10% glycerol, 5% b-mercaptoethanol and
0.01% bromophenol blue) and resolved on a 0.1% SDS-
10% PAGE essentially as described previously [11]. For
immunoblot, the SDS-PAGE resolved protein was elec-
trophoretically transferred overnight to a 0.45 μmn i t r o -
cellulose membrane (Bio-Rad, Hercules, CA, USA) at a
constant current of 50 milliampere in Tris-Glycine buffer
(25 mM of Tris-HCl and 200 mM glycine) containing
20% methanol. The membrane was then washed once
with phosphate buffered saline (PBS; 50 mM phosphate
and 150 mM NaCl, pH 7.4) and non-specific sites were
blocked with 3% BSA in PBS for 60 min at room tem-
perature (RT). All subsequent incubations were carried
out for 1 h at RT and each incubation was followed by
three washings with PBS containing 0.1% Tween-20.
Post-blocking, the membrane was processed for detection
of the recombinant protein by employing 1:100 dilution
of mouse polyclonal antibodies against ZP1 synthetic
peptide [P5; 26] followed by horse-radish peroxidase
(HRP)-conjugated goat anti-mouse immunoglobulin
(1:2000; Pierce, Rockford, IL, USA) as secondary antibody
essentially as described previously [11]. The blot was
developed with 0.6% (w/v) 4-chloro-1-naphthol
(Amresco) in 50 mM PBS containing 25% methanol and
0.06% H2O2.
To determine the glycosylation profile of recombinant
human ZP1273-551aa, a lectin-binding assay in an Enzyme
Linked Immunosorbent Assay (ELISA) format, was per-
formed [11]. As an internal control, E. coli-expressed
recombinant human ZP1273-551aa (unpublished observa-
tions) was also used. In brief, microtitration plates
(Nunclon™, Rosakilde, Denmark) were coated with the
recombinant proteins (500 ng/well) in 50 mM phos-
phate-buffered saline (PBS), pH 7.4 for 1 h at 37°C fol-
lowed by overnight incubation at 4°C. All subsequent
washings were done three times in 50 mM PBS with
0.05% Tween-20 (PBST). The plate was blocked with
0.1% Tween-20 in PBS (PBST, 200 μl/well) for 90 min
at 37°C followed by incubation with 21 biotinylated lec-
tins (1 μg/ml; 100 μl / w e l l )a t3 7 ° Cf o r1h .T h eb i o t i n y -
lated lectins available in the Lectin kit-I, II and III
(Vector Laboratories, Burlingame, CA, USA) were used
in the lectin binding assay. The bound lectins were
revealed by incubating with HRP-conjugated streptavi-
din (1:3000; Pierce; 100 μl/well) at 37°C for 1 h. The
enzyme activity was detected by adding 100 μl/well of
0.05% orthophenylenediamine and 0.06% H2O2 in
50 mM citrate phosphate buffer, pH 5.0 and the reac-
tion was stopped by adding 50 μl/well of 5 N H2SO4.
The absorbance was read at 490 nm with 630 nm as the
reference filter.
Fluorescein isothiocyanate (FITC) labelling of the
recombinant proteins
The purified recombinant human ZP1273-551aa (1 mg) was
dialyzed against 0.5 M carbonate buffer (pH 9.0) and incu-
bated with FITC Isomer I (Pierce) at a molar ratio of 1:24
for 90 min at RT with end-to-end mixing. Post-incubation,
unbound FITC was removed from the labelled recombi-
nant protein by extensive dialysis against PBS pH 7.4. All
the above treatments were performed under light-pro-
tected conditions. The fluorescein/recombinant protein
molar ratio (F/P) was determined by spectrophotometric
analysis and calculated using the following formula: Molar
F/P = (Molecular weight of the protein/389) × [(A495/
195)/A280-{(0.35 × A495)}/E
0.1%]
where: 389 is the molecular weight of FITC in Dal-
tons; 195 is the absorption E
0.1% of bound FITC at
495 nm at pH 13.0; (0.35 × A495) is the correction factor
due to the absorbance of FITC at 280 nm; E
0.1% is the
absorption at 280 nm of the protein at 1.0 mg/ml
Binding of recombinant human ZP1273-551aa to
capacitated human spermatozoa
All experiments using human spermatozoa were car-
ried out under informed consent and following the
clearance from the Institutional Bio-safety and Human
Ethical Committee. Semen samples were collected
from healthy donors and subjected to liquefaction at
RT for 30 min. The motile sperm were separated by a
two-step Percoll density gradient [27] and processed
for capacitation in Biggers-Whitten-Whittingham
(BWW) medium [28] supplemented with 2.6% bovine
serum albumin (BSA, cell culture grade; Sigma-Aldrich
Inc) essentially as described previously [11]. To pre-
pare acrosome-reacted sperm, capacitated sperm were
incubated with calcium ionophore A23187 (CaI;
10 μM, Sigma-Aldrich Inc) for 20 min at 37°C and 5%
CO2 in humidified air. Non-capacitated, capacitated
and acrosome-reacted spermatozoa (5 × 10
6), pre-fixed
for 10 min at RT with 0.5% paraformaldehyde, were
incubated with 2.5 μg of FITC-labelled recombinant
ZP1273-551aa in a reaction volume of 50 μla t3 7 ° Ca n d
5% CO2 in humidified air for 60 min. In all the experi-
ments, Fetuin (Sigma Aldrich Inc.) labelled with
FITC was used as negative control. In addition,
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human ZP1 and ZP3 [12,16] were also used as positive
controls. Post-incubation, sperm were processed for
simultaneous assessment of the status of acrosome by
double labelling with 5 μg/ml tetramethyl rhodamine
isothiocyanate conjugated Pisum sativum agglutinin
(TRITC-PSA; Vector Laboratories Inc., Burlingame,
CA, USA) and for binding of FITC-labelled human
ZP1273-551aa as described earlier [12].
Induction of acrosome reaction by recombinant human
ZP1273-551aa in capacitated human spermatozoa
Capacitated sperm (1 × 10
6 in BWW medium and
0.3% BSA) were incubated at 37°C with 5% CO2 in
humidified air for varying times and concentrations of
recombinant human ZP1273-551aa in a total reaction
volume of 100 μl and processed as described earlier
[29]. Sperm incubated with BWW supplemented with
0.3% BSA alone accounted for the spontaneous induc-
tion of acrosome reaction. Baculovirus-expressed
recombinant human ZP1 and ZP3 [[11,16]; 1 μg/reac-
tion] served as positive controls, whereas Fetuin and
baculovirus-expressed recombinant human ZP2 [12]
served as negative controls in all the experiments. In
addition, CaI (10 μM) was also used as positive control
in all the experiments. The effect of treatment of var-
ious recombinant proteins on sperm with respect to
viability by eosin-nigrosin staining [30] and total moti-
lity as per the WHO guidelines [31] were assessed.
After incubation with various test proteins, sperm were
washed twice with 50 mM PBS pH 7.4. Subsequently,
sperm pellet was resuspended in 100 μlP B Sa n d1 5μl
aliquots were spotted on poly-lysine coated slides
(Sigma-Aldrich Inc.) in duplicates, air dried and fixed
in chilled methanol for 30 sec. The slides were washed
once with PBS and stained with 5 μg/ml TRITC-PSA
for 30 min at RT. Sperm showing rhodamine fluores-
cence in the acrosomal region of the head were classi-
fied as acrosome intact while those that demonstrated
complete loss of PSA staining in the acrosome or
revealed staining at the equatorial region were denoted
as acrosome-reacted. All slides were read ‘blind’ with
coded samples. Two hundred sperm were scored
for every spot and results are represented as percent
stimulation of acrosome reaction which is calculated in
the following manner: % stimulation of acrosome
reaction = [(AR - negative control)/(CaI - negative
control)] × 100
where: AR is the percent induction of acrosome reac-
tion by various inducers, negative control is the sponta-
neous acrosome reaction and CaI is the percent
acrosome reaction by incubation with CaI.
Elucidation of the downstream signalling events
associated with human ZP1273-551aa mediated induction
of acrosomal exocytosis
Various pharmacological inhibitors at different concen-
trations, as described previously [16], were employed to
delineate the downstream signalling mechanism of the
acrosome reaction induced by recombinant human
ZP1273-551aa. Among these inhibitors are the extracellu-
lar calcium chelator: EGTA; L-Type voltage operated
Ca
2+ channel (VOCC) blockers: Nifedipine & Verapamil;
T-Type VOCC blockers: Amiloride & Pimozide; inhibi-
tor of Gi protein: Pertussis toxin (PTX); all of which
were pre-incubated with the sperm for 10 min (except
PTX, kept for 30 min incubation) at 37°C with 5% CO2
in humidified air prior to the addition of ZP1273-551aa.
All the above inhibitors were procured from Sigma-
Aldrich Inc.
Statistical analysis
In case of binding and induction of acrosome reaction
experiments, the results are expressed as mean ± SEM
of 3-4 different experiments using semen samples from
3 different male donors. The statistical analysis was
done by comparing the means of the negative control
(Fetuin) and experimental sets by using one way analysis
of variance (ANOVA) followed by Newman-Keuls
Multiple Comparison Test. The statistical analysis with
respect to the effect of various pharmacological inhibi-
tors on ZP1273-551aa-mediated induction of acrosome
reaction was performed by Student’s t-test. A p value of
≤ 0.05 was considered to be statistically significant.
Results
Characteristics of baculovirus-expressed recombinant
human ZP1273-551aa
The nucleotide (nt) sequencing of the cDNA encoding
ZP1273-551aa, PCR amplified from human ovarian cDNA
library, revealed three changes at 858, 867 and 1590 nt
positions as compared to human ZP1 sequence already
published in Genbank (NM_207341). However, these
changes did not lead to any change in the deduced aa
sequence. Recombinant human ZP1273-551aa expressed in
Sf21 insect cells was present both in the cell lysate as
well as the 10× concentrated culture supernatant (Figure
1, panel b and c respectively). The Sf21 cells infected
with wild type AcNPV, used as negative control, did not
show any reactivity with antibodies against ZP1 peptide.
The amount of secreted ZP1273-551aa present in the
culture medium was, however lower as compared to the
cell lysate. SDS-PAGE profile of the recombinant
human ZP1273-551aa, purified using Ni-NTA affinity
column from the cell lysate revealed a doublet with
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panel d). The recombinant protein purified from the
culture supernatant also showed the same profile in
Western blot as observed for the cell derived protein
(data not shown).
In lectin binding ELISA, baculovirus-expressed human
ZP1273-551aa exhibited strong reactivity with Concanava-
lin A (ConA) and weaker reactivity with Jacalin and
Wheat germ agglutinin (WGA) (Figure 2). The E. coli-
expressed recombinant human ZP1273-551aa used as an
internal control, failed to show any significant binding
to any of the lectins. While ConA has oligosaccharide
specificity towards mannose a 1-3 or mannose a 1-6
residues, Jacalin binds to a-O glycosides of Gal or
GalNac moieties. WGA has oligosaccharide specificity
towards GlcNac and neuraminic acid residues. While
ConA and WGA have oligosaccharide specificity
towards N-linked sugar residues, Jacalin detects the
presence of O-linked carbohydrate moieties.
Binding characteristics of recombinant human ZP1273-
551aa with capacitated human spermatozoa
Recombinant ZP1273-551aa conjugated to FITC as
described in Methods revealed molar F/P ratios of 1.1.
The FITC-labelled recombinant protein was analyzed
for binding to spermatozoa and the acrosomal status of
the spermatozoa was simultaneously assessed by double
labelling with TRITC-PSA. FITC-labelled recombinant
Figure 1 Design, expression, purification and characterization of the baculovirus-expressed recombinant human ZP1273-551aa. Panel (a)
represents the schematic diagram of the cDNA encoding human ZP1273-551aa with 6× His tag (His6) at C-terminus cloned in baculovirus transfer
vector, pAcGP67-A, using BamHI and EcoRI restriction sites downstream of gp67 insect secretory signal sequence under polyhedrin promoter
(Ppol). Sf21 cells (0.8 × 10
6) were infected with the recombinant or wild type AcNPV virus. After 96 h, the infected cells and supernatant were
harvested and processed for Western blot as described in Methods. Panels (b) & (c) represent immunoblot showing the expression of ZP1273-551aa
in cell pellet and 10× concentrated culture supernatant respectively from Sf21 cell infected with ZP1273-551aa-recombinant virus. Lanes 1 and 2
represent the cell pellet or culture supernatant of Sf21 cell infected with wild type AcNPV and ZP1273-551aa-recombinant virus respectively. Panel
(d) represents Coomassie stained SDS-PAGE profile of ZP1273-551aa purified from the cell pellet (lane 1, 5 μg/lane). Lane M represents molecular
weight markers.
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1.23%) to non-capacitated human sperm. Hence, all
further studies were done using capacitated spermato-
zoa. The baculovirus-expressed recombinant human
ZP1273-551aa showed binding to 19.67 ± 2.40% of acro-
some-intact and 15.62 ± 1.64% acrosome-reacted sperm
(Table 1). Under similar experimental conditions, FITC-
conjugated Fetuin, used as a negative control, bound to
3.95 ± 2.12% of acrosome-intact sperm while the posi-
tive controls, FITC-labelled baculovirus-expressed ZP3
and full length ZP1 bound to 26.08 ± 2.75% and 15.63 ±
1.88% of the acrosome-intact spermatozoa, respectively
(Table 1). Binding analysis with acrosome-reacted sperm
revealed that 22.65 ± 2.15% sperm bound to ZP3 and
14.40 ± 1.09% showed binding with full length ZP1
(Table 1). Careful examination of the profile of binding
revealed that approximately 70% sperm showed binding
of ZP1273-551aa to the acrosomal cap (Figure 3A) and
approximately 30% in the equatorial region of the acro-
some-intact human sperm (Figure 3B). In acrosome-
reacted spermatozoa, binding of ZP1273-551aa to the acro-
somal cap was lost and observed only in the equatorial
region (Figure 3C). Further, binding of FITC-labelled
baculovirus-expressed ZP3 and full length ZP1 was also
observed only in the equatorial segment of the acro-
some-reacted spermatozoa [12,16]. In addition, few sper-
matozoa also showed binding of FITC-labelled
recombinant ZP1273-551aa to either post acrosomal
region (Figure 3B) or mid-piece of acrosome-intact and
acrosome-reacted spermatozoa (data not shown).
The ‘ZP domain’ of human ZP1 induces acrosomal
exocytosis in capacitated human spermatozoa
Recombinant human ZP1273-551aa was evaluated for its
ability to induce acrosomal exocytosis in capacitated
human spermatozoa. No significant decrease in the
Figure 2 Profile of lectins binding to baculovirus-expressed human ZP1273-551aa in ELISA. Microtitration plates were coated with the
baculovirus-expressed recombinant ZP1273-551aa (open bar; 500 ng/well) and processed for evaluation of binding to 21 different biotinylated
lectins in an ELISA as described in Methods. As an internal control, microtitration plates coated with same amount of E. coli-expressed
recombinant human ZP1273-551aa (grey bar; unpublished observations) were also used. Values are expressed as absorbance obtained with various
lectins binding to the respective recombinant protein, after deducting the non-specific binding of the lectins to the uncoated wells. Each bar
represents a mean of duplicate experiments and standard deviation of the absorbance values. The lectins tested were GSL-I: Griffon simplicifolia
lectin I, SBA: Soybean agglutinin, DSL: Datura stramonium lectin, PSA: Pisum sativum agglutinin, ConA: Concanavalin A, ECL: Erythrina cristagalli
lectin, LCA: Lens culinaris agglutinin, DBA: Dolichos biflorus agglutinin, LEL: Lycopersicon esculentum lectin, PHA-L: Phaseolus vulgaris
leucoagglutinin, UEA-I: Ulex europaeus agglutinin I, STL: Solanum tuberosum lectin, PHA-E: Phaseolus vulgaris erythroagglutinin, RCA: Ricinus
communis agglutinin, VVA: Vicia villosa agglutinin, SJA: Sophora japonica agglutinin, PNA: Peanut agglutinin, S- WGA: Succinylated Wheat germ
agglutinin, Jacalin, WGA: Wheat Germ agglutinin and GSL II: Griffonia simplicifolia lectin II.
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following incubation with the recombinant protein.
Capacitated sperm incubated with purified recombinant
ZP1273-551aa showed a significant (p < 0.05) increase in
acrosomal exocytosis as compared to the medium con-
trol (Table 2). Baculovirus-expressed recombinant
human ZP3, used as a positive control, showed a signifi-
cant increase in acrosome reaction as compared to
Fetuin whereas baculovirus-expressed recombinant
human ZP2 [12] failed to do so (Table 2). Dose
response studies with baculovirus-expressed human
ZP1273-551aa revealed a significant increase in the acro-
some reaction at 500 ng/ml. The highest acrosome reac-
tion was observed at 2 μg/ml and hence all subsequent
experiments were performed using this amount of the
recombinant protein. Recombinant ZP1273-551aa purified
from culture supernatant also exhibited dose dependent
induction of acrosomal exocytosis comparable to cell
purified recombinant protein (Data not shown). Time
kinetic studies revealed that a significant increase in the
induction of acrosome reaction could be seen as early as
10 min after exposure of the capacitated sperm to the
recombinant ZP1273-551aa (Figure 4). Highest level of
induction of acrosome reaction was observed at 60 min.
Downstream signalling events associated with ZP1273-
551aa-mediated induction of acrosomal exocytosis
To elucidate the downstream signalling pathway
involved in acrosomal exocytosis mediated by the ‘ZP
domain’ of ZP1, different pharmacological inhibitors
were employed. The average viability in absence of phar-
macological inhibitors of the capacitated sperm ranged
from 85-90%. No significant change in the sperm viabi-
lity was observed subsequent to incubation with various
pharmacological inhibitors. No significant decrease in
ZP1273-551aa mediated induction of acrosome reaction
w a so b s e r v e d( p>0 . 0 5 )a f t e ri n c u b a t i o nw i t hP e r t u s s i s
toxin (0.1 μg/ml; 30 min pre-incubation) pre-treated
capacitated human spermatozoa (Figure 5) suggesting
that activation of Gi-protein coupled receptor is not
necessary for ‘ZP domain’ of ZP1 mediated acrosomal
exocytosis. Induction of acrosomal exocytosis mediated
by ZP1273-551aa required extracellular Ca
2+ as prior incu-
bation of capacitated sperm in BWW medium with
EGTA before exposing to recombinant protein led to a
significant decrease in acrosomal exocytosis (p < 0.01,
Figure 5). Both L- and T- type Ca
2+ channels seem to
p l a yar o l ei nZ P 1 273-551aa mediated induction of acro-
some reaction as inhibitors for both types of channels
resulted in a significant decrease in acrosomal exocytosis
(Figure 6).
Discussion
In order to understand the molecular basis of fertilization
in humans, it is imperative to delineate the role of ZP gly-
coproteins during different stages of fertilization. In this
direction, a recent study demonstrated that human ZP1
in addition to ZP3 and ZP4 binds to capacitated human
spermatozoa and induces acrosomal exocytosis [16]. To
investigate whether the ‘ZP domain’ of human ZP1 also
plays a functional role, the fragment 273-551 aa residues,
comprising of the ‘ZP domain’ of ZP1 was cloned and
expressed in the baculovirus expression system. We have
opted for the baculovirus expression system over the
mammalian expression system as recombinant human
ZP1, ZP3 and ZP4 obtained using this expression system
not only bind to capacitated acrosome-intact spermato-
zoa but also induce acrosome reaction in a dose depen-
dent manner [9,11,12,16,32]. These studies are further
corroborated by observations that baculovirus-expressed
Table 1 Binding characteristics of FITC-labelled recombinant ZP1273-551aa with capacitated human spermatozoa in
direct binding assay





Fetuin 3.95 ± 2.12
*ZP3 26.08 ± 2.75 p = 0.0004
c
*ZP1 15.63 ± 1.88 p = 0.0019
c
ZP1273-551aa 19.67 ± 2.40 p = 0.0010
c
Acrosome-reacted sperm
Fetuin 5.8 ± 3.60
*ZP3 22.65 ± 2.15
a p = 0.0021
c
*ZP1 14.40 ± 1.09
a p = 0.0156
c
ZP1273-551aa 15.62 ± 1.64
a p = 0.0117
c
*Baculovirus-expressed recombinant human ZP1 and ZP3 labelled with FITC;
aBinding observed only in the equatorial region
bStatistical significance with respect to the binding values of Fetuin was calculated by one way ANOVA followed by Newman-Keuls Multiple Comparison Test.
cValues are statistically significant.
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Page 7 of 14recombinant rabbit 55 kDa protein (homolog of human
ZP4) binds in a dose dependent manner to the rabbit
sperm [33]. However, recombinant porcine ZP4
expressed in insect cells binds to bovine but not porcine
sperm which may be due to the glycosylation profile of
recombinant protein being similar to bovine rather than
porcine ZP4 [34]. Transfer vector (pAcGP67-A) having
the gp67 insect signal sequence was used to express
human ZP1273-551aa, which facilitates its proper post-
translational processing through ER-Golgi pathway.
Further, the levels of expressed protein are high as an
average yield of 250-500 μg of purified baculovirus-
expressed protein was obtained from each round of puri-
fication using 150 × 10
6 recombinant virus-infected Sf21
cells, thus facilitating availability of sufficient amounts of
purified protein to perform various assays.
The baculovirus-expressed human ZP1273-551aa showed
two bands in SDS-PAGE as well as Western blot which
Figure 3 Binding profile of recombinant human ZP1273-551aa with human spermatozoa. Capacitated/acrosome-reacted sperm (5 × 10
6/50
μl) were incubated with 2.5 mg of FITC conjugated baculovirus-expressed ZP1273-551aa and processed as described in Methods. Panels (A) and (B)
represent the binding of FITC conjugated ZP1273-551aa with capacitated acrosome intact sperm whereas Panel (C) depicts the binding profile with
acrosome-reacted spermatozoa. The acrosomal status was determined by labeling the sperm with TRITC-PSA. The images were captured using
Eclipse 80i fluorescence microscope (Nikon). In each panel, the sub-panels are represented as a: phase contrast; b: TRITC-PSA fluorescence; c:
FITC-ZP protein fluorescence and d: overlap of fluorescent frames. The scale bar represents 2.5 μm.
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Page 8 of 14Table 2 Induction of acrosome reaction by baculovirus-expressed recombinant human ZP1273-551aa in capacitated
human spermatozoa





Fetuin (10 μg/ml) 7.6 ± 1.8
ZP1 (10 μg/ml) 33.2 ± 2.9 p = 0.0065*
ZP2 (10 μg/ml) 10.9 ± 2.4 p = 0.6085
ZP3 (10 μg/ml) 42.3 ± 3.2 p = 0.0023*
ZP1273-551aa
500 ng/ml 17.2 ± 1.6 p = 0.0391*
1 μg/ml 30.1 ± 0.6 p = 0.0078*
2 μg/ml 58.2 ± 1.7 p = 0.0002*
5 μg/ml 40.5 ± 0.6 p = 0.0007*
10 μg/ml 41.6 ± 1.7 p = 0.0016 *
aPercent stimulation of acrosomal exocytosis was calculated as stated in Methods. Values represent mean ± SEM of at least four independent experiments.
bStatistical significance with respect to the acrosome reaction induced by Fetuin was calculated by one way ANOVA followed by Newman-Keuls Multiple
Comparison Test.
*Values are statistically significant.
Figure 4 Time kinetic analysis of ZP1273-551aa induced acrosome reaction. Capacitated sperm (1 × 10
6/100 μl) were incubated with or
without 2 μg/ml of ZP1273-551aa for varying time points and subsequently analyzed for acrosomal status by TRITC-PSA staining as described in
Methods. Y-axis represents effective induction of acrosome reaction which is the percent induction of acrosome reaction in presence of ZP1273-
551aa minus the percent induction of acrosome reaction observed in the presence of medium alone. Values are Mean ± SEM of 3 different
experiments using semen samples from at least two different male donors. *p < 0.01, statistical significance with respect to the effective
induction of acrosome reaction mediated by ZP1273-551aa at 2.5 minutes.
Ganguly et al. Reproductive Biology and Endocrinology 2010, 8:110
http://www.rbej.com/content/8/1/110
Page 9 of 14may be due to differential glycosylation of the expressed
protein. Expression of human ZP1273-551aa in Sf21 cells
in presence of Tunicamycin (20 μg/ml, Sigma-Aldrich
Inc), which inhibit N-linked glycosylation, resulted in a
single band (data not shown) suggesting that the two
bands represent different glycoforms of expressed
recombinant protein. Observation of more than one
band of human zona glycoproteins expressed using
baculovirus expression system has also been reported
previously [29]. The apparent higher molecular weight
of the baculovirus-expressed protein as compared to the
calculated molecular weight of 30.8 kDa may be due to
the glycosylation as revealed by the binding of various
lectins. Binding of recombinant human ZP1273-551aa with
ConA (specific for mannose a 1-3/1-6 residues,
N-linked), WGA (GlcNac and neuraminic acid residues,
N-linked) and Jacalin (specific for a-O glycosides of Gal
or GalNAc moieties, O-linked) suggest the presence of
both N- and O-linked glycosylation. Using immunocyto-
chemistry, a study has also shown the presence of both
ConA and Jacalin binding to the native human ZP [35].
The presence of very high concentration of D-mannose
residues in human ZP has earlier also been documented,
reflecting a high content of asparagine-linked oligosac-
charides [36]. Characterization of the glycosylation pro-
file of the purified native human ZP3 and ZP4 revealed
that it is predominantly N-linked [13].
It was observed that recombinant baculovirus-
expressed ZP1273-551aa was secreted in the supernatant
in very low amounts. It has been reported previously
that the secretion of a lutropin protein receptor
expressed using the baculovirus expression system was
dependant both on the presence of the signal peptide as
well as the promoter [37]. The temporal activity (early
or late) of a promoter induces drastic changes in the
pattern of protein processing. In Sf9 insect cells, the
secretory pathway of the cells was seen to be compro-
mised in the late stages of baculovirus infection [38,39].
Using the late core-protein promoter instead of the very
late polyhedrin promoter, secretion of beta-human chor-
ionic gonadotropin was increased, although not at the
level of the native protein [40]. Hence, expression of
recombinant human ZP1273-551aa under the control of
very late polyhedrin promoter may be one of the
reasons behind the poor levels of secretion of the
recombinant protein in spite of the presence of insect
secretory sequence in the pAcGP67-A vector. Hence,
functional studies were performed using the protein
purified from the cell pellet and subsequently induction
of acrosome reaction was confirmed with the protein
purified from the culture supernatant.
Studies have shown that in humans ZP1, ZP3 and ZP4
bind to capacitated human sperm [12,13,16]. In the pre-
sent study, for the first time, it has been demonstrated
that the ‘ZP domain’ module of ZP1 binds to capaci-
tated spermatozoa. The observed higher bindings (statis-
tically non significant) of ‘ZP domain’ of ZP1 as
compared to full length ZP1 to the capacitated acro-
some-intact spermatozoa may be due to the differences
in the accessibility of the binding domains/regions pre-
sent on these proteins to the spermatozoa. Low binding
percentage of ‘ZP domain’ of ZP1 to capacitated acro-
some-intact spermatozoa in the present study may be
corroborated by a report where more than 75% of
motile sperm from fertile men have been shown to be
incapable of binding to native ZP [41]. An alternate
plausible explanation for low binding may also be due
to different maturation stages of the sperm present in
the human semen. The observed low binding may not
Figure 5 Role of extracellular calcium and Gi protein-coupled
receptor in ZP1273-551aa- mediated induction of acrosomal
exocytosis. Capacitated sperm (1 × 10
6/100 μl) were pre-treated
with 8 mM EGTA (10 min prior-incubation) and 0.1 μg/ml PTX (30
min prior-incubation) to study effects of extracellular calcium and Gi
protein respectively. These pretreated sperm were incubated with
ZP1273-551aa (2 μg/ml) for 60 min, and subsequently analyzed for
acrosomal status by TRITC-PSA staining as described in Methods.
Spontaneous acrosome reaction was assessed by incubating sperm
only with BWW medium. Data has been represented as percent
stimulation of acrosome reaction calculated as described in
Methods. Values are Mean ± SEM of 3 different experiments using
semen samples from at least two different male donors. *p < 0.01,
statistical significance with respect to the percent stimulation of
acrosome reaction mediated by ZP1273-551aa.
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Page 10 of 14be due to the impaired biological activity of recombi-
nant human ZP1273-55aa post-labelling with FITC as
comparable binding percentages were observed when
either FITC-labelled baculovirus-expressed recombinant
human ZP3 and ZP4 or solubilized human ZP were
used as shown previously [12].
Successful mammalian fertilization requires capaci-
tated spermatozoa to undergo acrosome reaction. High
resolution scanning electron microscopy studies revealed
that the ZP matrix of human oocytes is made-up of a
delicate meshwork of thin interconnected filaments in a
regular alternating pattern of wide and tight meshes/
pores [42]. Capacitated human sperm incubated with
intact human zonae or acid disaggregated zonae led to a
significant increase in acrosome reaction [43,44]. To
delineate the role of individual zona proteins in the
induction of acrosome reaction, various groups have
either used the purified protein from native source (dif-
ficult to rule out minor contaminants of other egg asso-
ciated or zona proteins) or recombinant protein. The
studies presented in this manuscript showed that the
baculovirus-expressed recombinant human ZP1273-551aa
Figure 6 Role of voltage operated Ca
2+ channels (VOCCs) in ZP1273-551aa- mediated induction of acrosomal exocytosis. Capacitated
sperm (1 × 10
6/100 μl) pre-treated with 10 μM Verapamil, 10 μM of Nifedipine (10 min prior-incubation with each to study effect of blocking of
L-type VOCC), 10 μM Pimozide and 100 μM Amiloride (10 min pre-incubation; to study effect of blocking of T-type VOCC) were incubated with 2
μg/ml of ZP1273-551a for 60 min and subsequently analyzed for acrosomal status by TRITC-PSA staining as described in Methods. Spontaneous
acrosome reaction (spontaneous AR) was analyzed by incubating sperm only with BWW medium. Additional negative controls comprised of the
same amount of dimethyl sulphoxide (DMSO) and ethanol (EtOH) as used to dissolve T- and L-type VOCC inhibitors. Data has been represented
as percent stimulation of acrosome reaction calculated as described in Methods. Values are Mean ± SEM of 3 different experiments using semen
samples from at least two different male donors. *p < 0.05, statistical significance with respect to the percent stimulation of acrosome reaction
mediated by ZP1273-551aa.
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response results indicate that as little as 500 ng/ml of
baculovirus-expressed recombinant ZP1273-551aa is suffi-
cient to induce a significant acrosome reaction in capa-
citated human sperm, though the maximum induction
of acrosome reaction was observed at 2 μg/ml (Table 2).
The amount of recombinant protein required to induce
acrosome reaction far exceeds that present in the ZP
matrix. It may be due to the presence of other factors in
the female reproductive tract that may act in synergy
with the zona proteins to bring about acrosomal exocy-
tosis in the sperm [45]. Further, based on recent studies
by our group and others, the observed acrosomal exocy-
tosis mediated by ZP may be due to a combined effect
of ZP1, ZP3 and ZP4 [9,11,12,14,16,32]. The observed
ability of the baculovirus-expressed ZP1273-551aa to
induce acrosome reaction is not due to post mortem
acrosomal loss as no change either in the sperm percent
motility or in the sperm viability was observed when the
sperm were incubated with the recombinant protein.
It has been proposed that ZP glycoproteins mediate
acrosomal exocytosis involving two different signalling
pathways. One is a tyrosine kinase receptor coupled to
phospholipase Cg (PLCg) and the other is the Gi pro-
tein-coupled receptor that activates phospholipase Cb1
(PLCb1) mediated signalling pathway [14,46,47]. Pertus-
sis toxin, an inhibitor of Gi protein mediated signalling
pathway did not inhibit the acrosome reaction mediated
by recombinant baculovirus-expressed human ZP1273-
551aa suggesting that it acts in a similar fashion as
human ZP4 and the full length human ZP1 [11,14,16].
However, the same concentration of Pertussis toxin
under similar experimental conditions significantly
inhibited the baculovirus-expressed human ZP3
mediated induction of acrosome reaction [11]. These
results suggest that ZP3 uses Gi protein-coupled recep-
tor pathway whereas ZP1/ZP4 are not dependent on its
activation to induce acrosomal exocytosis.
Extracellular Ca
2+ is required to bring about ZP1-
mediated acrosomal exocytosis [16] and both T- and L-
type VOCCs are involved in the downstream signalling
pathway. The concentrations of the VOCCs inhibitors
employed in these studies were decided upon by review-
ing the various studies done employing the same inhibi-
tors, published previously [14,48,49]. The above studies
therefore, reveal that the downstream signalling pathway
of ZP1273-551aa-induced acrosome reaction shows simi-
larity to the one elucidated for full length human ZP1
and ZP4 [14,16]. Both follow the Gi protein independent
pathway, both involve activation of L- and T- type
VOCCs [14,16]. These findings can be vindicated by the
fact that within the four human ZP glycoproteins, ZP1
and ZP4 share the maximum sequence identity of 47%
with each other hence, the similarity in their mechanism
of action.
All ZP glycoproteins (except for cat ZP3 and mouse
ZP1) share a homologous region designated as the ‘ZP
domain’ which is also present in several eukaryotic
extra-cellular proteins [19,21]. The ‘ZP domain’ consists
of approximately 260 aa including 8 conserved Cys resi-
dues and is predicted to have high b-strand content
with additional conservation of hydrophobicity, polarity
and turn forming tendency at a number of positions
[19,21]. In humans, ‘ZP domain’ module of ZP1 corre-
sponds to 279-549 aa, ZP2 from 372 to 637 aa, ZP3
from 45 to 303 aa and ZP4 from 188-460 aa. Compari-
son of the aa sequence of ‘ZP domain’ of human ZP1
revealed sequence identity of 29% with the ‘ZP domain’
of ZP2, 18% with ZP3 and 47% with ZP4, suggesting
thereby significant variations at the aa level in spite of
having conserved ‘ZP domain’ motif. Human ZP3 ‘ZP
domain’ consists of two conserved sub-domains, N-
terminal (ZP-N) followed by internal hydrophobic patch
(IHP, 167-173 aa) and C-terminal (ZP-C) followed by
external hydrophobic patch (EHP, 362-368 aa) separated
by a short protease sensitive hinge. The polymerisation
property of the ‘ZP domain’ is most likely imparted by
t h ep r e s e n c eo ft h eZ P - Ns u bd o m a i na sP L A C - 1l i k e
proteins consisting of only ZP-N domain can polymerize
and majority of ‘ZP domain’ mutations causing disease
in humans, such as those in a-tectorin and Tamm-hors-
fall protein, are clustered within the first half of the
domain [20,23,50-52]. ZP-C sub-domain on the other
hand, is found only as part of a complete ‘ZP domain’
and can adopt different disulfide connectivities
[21,53,54] and hence, it may play a crucial role in regu-
lating the specificity of the ZP-N sub-domain to deter-
mine whether or not a given ‘ZP domain’ protein can
homo- or hetero-polymerize. Using various fragments of
baculovirus-expressed recombinant human ZP3, we
showed that the fragments corresponding to 214-348 aa
and 214-305 aa are able to induce AR where as frag-
m e n tc o r r e s p o n d i n gt o1 - 1 7 5a af a i l e dt od os o[ 2 9 ] .
These experiments suggest that the C-terminal fragment
of ZP3 ‘ZP domain’ is involved in the induction of AR.
Further studies are required to delineate the role of ‘ZP
domain’ of ZP2 and ZP4 in induction of AR. How cru-
cial is the glycosylation pattern to determine ‘ZP
domains’ ability of different zona proteins to induce AR
needs to be investigated. The unpublished observations
from our group has shown that E. coli-expressed ‘ZP
domain’ of human ZP1, presumably devoid of glycosyla-
tion, failed to induce AR suggesting that glycosylation
have critical role in induction of AR.
In humans, in addition to ZP3, ZP1 and ZP4 also
induce acrosome reaction [5-9,11,12,14,16]. Studies from
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bonnet monkey have also suggested that more than one
zona protein is involved in binding to the capacitated
spermatozoa and induction of acrosome reaction
[33,55-57]. Delineation of downstream signalling path-
way revealed that human ZP3 involves Gi protein-recep-
tor coupled pathway and primarily use T-type VOCCs
whereas induction of AR by human ZP1/ZP4 is inde-
pendent of Gi protein-receptor coupled pathway and
involve both L- and T- type VOCCs. The results pre-
sented in this manuscript suggest, for the first time, that
the ‘ZP domain’ of recombinant human ZP1 has func-
tional activity.
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